Background: Candlenut (CN) has been used indiscriminately for weight loss. In vivo effects of CN in different doses are scarce.

Objective: To evaluate the effects of CN ingestion in obese rats.

Design: Thirty animals (obese and non-obese) received one of three different types of treatments: placebo, CN ingestion in a popular therapeutic regimen (8 days with oral administration of 0.2 mg/kg followed by 20 days with doses of 0.4 mg/kg), and ingestion of a doubled popular dose-called 2CN. Treatment was maintained for 28 days.

Results: The fatty acid profile of CN indicated mainly linolelaidic and palmitoleic acids. Rats receiving CN and 2CN showed reduced plasmatic levels of glucose and lipoproteins (p < 0.05). A dose-dependent carcass fat reduction was observed (p < 0.05). Blood levels of aspartate aminotransferase (AST) and gamma-glutamyl transferase (GGT) reduced with CN and increased with 2CN doses (p < 0.05). Alanine aminotransferase (ALT) and the atherogenic index remained similar among all treatments (p > 0.05). Hepatic vacuolation decreased with CN, but the 2CN dose produced mononuclear leucocyte infiltrate.

Conclusions: Although CN presented beneficial effects on the metabolism of rats, it also caused increased risk of liver damage.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178887PMC
http://dx.doi.org/10.1186/s13098-022-00847-4DOI Listing

Publication Analysis

Top Keywords

fatty acids
4
acids composition
4
composition vivo
4
vivo biochemical
4
biochemical effects
4
effects aleurites
4
aleurites moluccana
4
moluccana seed
4
seed candlenut
4
candlenut obese
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!